The authors thank NCATS staff for their leadership and support in this important endeavor. The authors wish to acknowledge the contributions of the following TIN team members: from the Duke/Vanderbilt TIC: Princess Abbott, MPH, Jesse Hickerson, MBA, Jacqueline Huvane, PhD, Theresa Jasion, MSIS, Lori Poole, BA, PMP, Duke University, Durham, NC; Julia Dunagan, MBA, Terri Edwards, RN, RAC, Michelle Inigo Jones, MEd, Colleen Lawrence, PhD, CCRC, Wendy Lloyd, BA, LPN, CCRP, Emily Sheffer, MPA, from Vanderbilt University Medical Center, Nashville, TN; from the Johns Hopkins University/Tufts University TIC: Karen Lane, CRA, CCRP, Steve Mayo, Ph.D., Nichol McBee, MPH, CCRP, Lindsay Eyzaguirre, MS, Andrew Mould, MPH, from Johns Hopkins University, Baltimore, MD; Sheeona Gorman, Ph.D., Giuliana Green, BSc, Elizabeth Patchen, Tufts University, Boston, MA; from the Utah TIC, Stephanie Bisping, BSN, RN, CCRP, Jeri Burr, MS, RN-BC, CRC, FACRP, Marianne Gildea, RN, BSN, MS, CCRC, Marie Kay, BA, CCRC, Dixie Thompson, BSN, RN, University of Utah, Salt Lake City, UT; from the Vanderbilt RIC: Leslie Boone, MPH, Sarah Nelson, MS, Mary Stroud, RN, CCRP, Vanderbilt University Medical Center, Nashville, TN.
2. Sertkaya, A, et al. Examination of Clinical Trial Costs and Barriers for Drug Development. Lexington, MA: Eastern Research Group, Inc, 2014.
3. Ioannidis, JPA. Why most published research findings are false. PLoS Medicine 2005; 2: e124.
4. Zerhouni, EA. Translational and clinical science–time for a new vision. New England Journal of Medicine 2005; 353: 1621–1623.
5. Califf, RM, Berglund, L. Linking scientific discovery and better health for the nation: the first three years of the NIHʼs Clinical and Translational Science Awards. Academic Medicine 2010; 85: 457–462.
6. Reis, SE, et al. Reengineering the National Clinical and Translational Research Enterprise: The Strategic Plan of the National Clinical and Translational Science Awards Consortium. Academic Medicine: Journal of the Association of American Medical College 2010; 85: 463–469.
7. Shah, M, et al. Early vision for the CTSA program Trial Innovation Network: a perspective from the national center for advancing translational sciences: early vision for the CTSA Program Trial Innovation Network. Clinical Translational Science 2017; 10: 311–313.
8. Joosten, YA, et al. Community engagement studios: a structured approach to obtaining meaningful input from stakeholders to inform research. Academic Medicine 2015; 90: 1646–1650.
9. Selker, HP, et al. A proposal for integrated efficacy-to-effectiveness (E2E) clinical trials. Clinical Pharmacology & Therapeutics 2014; 95: 147–153.
10. Schulman, KA, et al. A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors. New England Journal of Medicine 2002; 347: 1335–1341.
11. Kiriakis, J, et al. Observational study of contracts processing at 29 CTSA sites: contracts processing at CTSAs. Clinical Translational Science 2013; 6: 279–285.
12. Farfel, G, Neuer, A. Faster Study Start-Up and Reduced Costs Through the Use of Clinical Document Exchange Portals. New York: Intralinks, 2009.